PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD19, 25 μg
PE/Dazzle™ 594 anti-mouse CD196 (CCR6), 100 μg
PE/Dazzle™ 594 anti-mouse CD196 (CCR6), 25 μg
PE/Dazzle™ 594 anti-mouse CD197 (CCR7), 100 μg
PE/Dazzle™ 594 anti-mouse CD197 (CCR7), 25 μg
PE/Dazzle™ 594 anti-mouse CD206 (MMR), 100 μg
PE/Dazzle™ 594 anti-mouse CD206 (MMR), 25 μg
PE/Dazzle™ 594 anti-mouse CD223 (LAG-3), 100 μg
PE/Dazzle™ 594 anti-mouse CD223 (LAG-3), 25 μg
PE/Dazzle™ 594 anti-mouse CD226 (DNAM-1), 100 μg
PE/Dazzle™ 594 anti-mouse CD226 (DNAM-1), 25 μg
PE/Dazzle™ 594 anti-mouse CD23, 100 μg
PE/Dazzle™ 594 anti-mouse CD23, 25 μg
PE/Dazzle™ 594 anti-mouse CD24, 100 μg
PE/Dazzle™ 594 anti-mouse CD24, 25 μg
PE/Dazzle™ 594 anti-mouse CD25, 100 μg